Alterations in regulons involving DLX5/6 or DLX6-AS1 have been implicated in psychiatric disorders such as autism and schizophrenia [54,84,85], as well as Alzheimer’s disease and major depressive disorders [86]. This evidence concerns the gene DLX6 and early-onset autosomal dominant Alzheimer disease.